First Header Logo Second Header Logo

Connection

Michael Shapiro to Atherosclerosis

Back to Details
This is a "connection" page, showing publications Michael Shapiro has written about Atherosclerosis.
Michael Shapiro
Connection Strength
10.772
Atherosclerosis
  1. Shapiro MD, German CA. Early Inclisiran Use in Atherosclerotic Cardiovascular Disease: Overcoming Therapeutic Inertia. J Am Coll Cardiol. 2024 May 21; 83(20):1953-1956.
    View in: PubMed
    Score: 0.605
  2. German CA, Shapiro MD. Charting a Course for Atherosclerosis Regression: Shifting the Paradigm. J Am Coll Cardiol. 2023 Nov 28; 82(22):2084-2086.
    View in: PubMed
    Score: 0.585
  3. Hammoud A, Chen H, Ivanov A, Yeboah J, Nasir K, Cainzos-Achirica M, Bertoni A, Khan SU, Blaha M, Herrington D, Shapiro MD. Implications of Social Disadvantage Score in Cardiovascular Outcomes and Risk Assessment: Findings From the Multi-Ethnic Study of Atherosclerosis. Circ Cardiovasc Qual Outcomes. 2023 Jul; 16(7):e009304.
    View in: PubMed
    Score: 0.569
  4. Freeman AM, Raman SV, Aggarwal M, Maron DJ, Bhatt DL, Parwani P, Osborne J, Earls JP, Min JK, Bax JJ, Shapiro MD. Integrating Coronary Atherosclerosis Burden and Progression with Coronary Artery Disease Risk Factors to Guide Therapeutic Decision Making. Am J Med. 2023 Mar; 136(3):260-269.e7.
    View in: PubMed
    Score: 0.548
  5. Rikhi R, Shapiro MD. Assessment of Atherosclerotic Cardiovascular Disease Risk in Primary Prevention. J Cardiopulm Rehabil Prev. 2022 Nov 01; 42(6):397-403.
    View in: PubMed
    Score: 0.543
  6. Rikhi R, Hammoud A, Ashburn N, Snavely AC, Michos ED, Chevli P, Tsai MY, Herrington D, Shapiro MD. Relationship of low-density lipoprotein-cholesterol and lipoprotein(a) to cardiovascular risk: The Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis. 2022 Dec; 363:102-108.
    View in: PubMed
    Score: 0.541
  7. McNavish DE, German CA, Shapiro MD. Should a Statin be Given to All Hypertensive Patients? Curr Hypertens Rep. 2022 Jan; 24(1):21-27.
    View in: PubMed
    Score: 0.515
  8. Mehta A, Shapiro MD. Apolipoproteins in vascular biology and atherosclerotic disease. Nat Rev Cardiol. 2022 Mar; 19(3):168-179.
    View in: PubMed
    Score: 0.505
  9. Mahmood T, Shapiro MD. The Questions on Everyone's Mind: What is and Why Do We Need Preventive Cardiology? Methodist Debakey Cardiovasc J. 2021; 17(4):8-14.
    View in: PubMed
    Score: 0.503
  10. Zhang W, Speiser JL, Ye F, Tsai MY, Cainzos-Achirica M, Nasir K, Herrington DM, Shapiro MD. High-Sensitivity C-Reactive Protein Modifies the Cardiovascular Risk of Lipoprotein(a): Multi-Ethnic Study of Atherosclerosis. J Am Coll Cardiol. 2021 Sep 14; 78(11):1083-1094.
    View in: PubMed
    Score: 0.503
  11. Mahmood T, Shapiro MD. Future role of proprotein convertase subtilisin/kexin type 9 inhibitors in preventive cardiology. Curr Opin Cardiol. 2019 09; 34(5):519-525.
    View in: PubMed
    Score: 0.436
  12. Kheiri B, Barbarawi M, Bachuwa G, Shapiro MD. Aspirin for Primary Prevention of Cardiovascular Disease. Circ Cardiovasc Qual Outcomes. 2019 06; 12(6):e005846.
    View in: PubMed
    Score: 0.429
  13. Sandesara PB, Virani SS, Fazio S, Shapiro MD. The Forgotten Lipids: Triglycerides, Remnant Cholesterol, and Atherosclerotic Cardiovascular Disease Risk. Endocr Rev. 2019 04 01; 40(2):537-557.
    View in: PubMed
    Score: 0.424
  14. Shapiro MD, Fazio S. Biologic bases of residual risk of cardiovascular events: A flawed concept. Eur J Prev Cardiol. 2018 11; 25(17):1831-1835.
    View in: PubMed
    Score: 0.408
  15. Shapiro MD, Tavori H, Fazio S. PCSK9: From Basic Science Discoveries to Clinical Trials. Circ Res. 2018 05 11; 122(10):1420-1438.
    View in: PubMed
    Score: 0.399
  16. Shapiro MD, Fazio S. PCSK9 and Atherosclerosis - Lipids and Beyond. J Atheroscler Thromb. 2017 May 01; 24(5):462-472.
    View in: PubMed
    Score: 0.367
  17. Shapiro MD, Fazio S. From Lipids to Inflammation: New Approaches to Reducing Atherosclerotic Risk. Circ Res. 2016 Feb 19; 118(4):732-49.
    View in: PubMed
    Score: 0.342
  18. Nielsen RV, Fuster V, Bundgaard H, Fuster JJ, Johri AM, Kofoed KF, Douglas PS, Diederichsen A, Shapiro MD, Nicholls SJ, Nordestgaard BG, Lindholt JS, MacRae C, Yuan C, Newby DE, Urbina EM, Bergström G, Ridderstråle M, Budoff MJ, Bøttcher M, Raitakari OT, Hansen TH, Näslund U, Sillesen H, Eldrup N, Ibanez B. Personalized Intervention Based on Early Detection of Atherosclerosis: JACC State-of-the-Art Review. J Am Coll Cardiol. 2024 May 28; 83(21):2112-2127.
    View in: PubMed
    Score: 0.152
  19. Muluk P, Zhu J, Thoma F, Hay E, Marroquin O, Makani A, Aiyer A, Nasir K, Gulati M, Shapiro MD, Mulukutla S, Saeed A. Impact of Guideline-Directed Statin Intervention for Primary Prevention in Patients With Diabetes. Diabetes Care. 2023 Dec 01; 46(12):2273-2277.
    View in: PubMed
    Score: 0.146
  20. Ashburn NP, Snavely AC, Rikhi R, Shapiro MD, Chado MA, Stopyra JP, Mahler SA. Preventive Cardiovascular Care for Hypercholesterolemia in US Emergency Departments: A National Missed Opportunity. Crit Pathw Cardiol. 2023 Dec 01; 22(4):110-113.
    View in: PubMed
    Score: 0.145
  21. Patel KV, Budoff MJ, Valero-Elizondo J, Lahan S, Ali SS, Taha MB, Blaha MJ, Blankstein R, Shapiro MD, Pandey A, Arias L, Feldman T, Cury RC, Cainzos-Achirica M, Shah SH, Ziffer JA, Fialkow J, Nasir K. Coronary Atherosclerosis Across the Glycemic Spectrum Among Asymptomatic Adults: The Miami Heart Study at Baptist Health South Florida. Circ Cardiovasc Imaging. 2023 Oct; 16(10):e015314.
    View in: PubMed
    Score: 0.145
  22. Kazibwe R, Chevli PA, Evans JK, Allison M, Michos ED, Wood AC, Ding J, Shapiro MD, Mongraw-Chaffin M. Association Between Alcohol Consumption and Ectopic Fat in the Multi-Ethnic Study of Atherosclerosis. J Am Heart Assoc. 2023 Sep 19; 12(18):e030470.
    View in: PubMed
    Score: 0.144
  23. Bhatia HS, Rikhi R, Allen TS, Yeang C, Guan W, Garg PK, Tsai MY, Criqui MH, Shapiro MD, Tsimikas S. Lipoprotein(a) and the pooled cohort equations for ASCVD risk prediction: The Multi-Ethnic Study of Atherosclerosis. Atherosclerosis. 2023 Sep; 381:117217.
    View in: PubMed
    Score: 0.143
  24. Krittanawong C, Maitra NS, El-Sherbini AH, Shah N, Lavie CJ, Shapiro MD, Virani SS. Lipoprotein(a) in clinical practice: A guide for the clinician. Prog Cardiovasc Dis. 2023; 79:28-36.
    View in: PubMed
    Score: 0.143
  25. Mehta A, Dixon DL, Saeed A, Kelly MS, Gulati M, Shapiro MD, Sperling LS, Virani SS. With Current Safety and Efficacy Data, Should Statins Be Made Available as Nonprescription Over-the-Counter Drugs? Curr Cardiol Rep. 2023 May; 25(5):423-430.
    View in: PubMed
    Score: 0.140
  26. Acquah I, Hagan K, Javed Z, Taha MB, Valero-Elizondo J, Nwana N, Yahya T, Sharma G, Gulati M, Hammoud A, Shapiro MD, Blankstein R, Blaha MJ, Cainzos-Achirica M, Nasir K. Social Determinants of Cardiovascular Risk, Subclinical Cardiovascular Disease, and Cardiovascular Events. J Am Heart Assoc. 2023 Mar 21; 12(6):e025581.
    View in: PubMed
    Score: 0.139
  27. Issa R, Nazir S, Khan Minhas AM, Lang J, Ariss RW, Kayani WT, Khalid MU, Sperling L, Shapiro MD, Jneid H, Gupta R. Demographic and regional trends of peripheral artery disease-related mortality in the United States, 2000 to 2019. Vasc Med. 2023 Jun; 28(3):205-213.
    View in: PubMed
    Score: 0.138
  28. Al Rifai M, Szklo M, Patel J, Blaha MJ, Ballantyne CM, Bittner V, Morris P, McEvoy JW, Shapiro MD, Al-Mallah MH, Greenland P, Virani SS. Statin Use and Risk of Diabetes by Subclinical Atherosclerosis Burden (from a Multi-Ethnic Study of Atherosclerosis Report). Am J Cardiol. 2022 Dec 01; 184:7-13.
    View in: PubMed
    Score: 0.135
  29. Alfaddagh A, Kapoor K, Dardari ZA, Bhatt DL, Budoff MJ, Nasir K, Miller M, Welty FK, Miedema MD, Shapiro MD, Tsai MY, Blumenthal RS, Blaha MJ. Omega-3 fatty acids, subclinical atherosclerosis, and cardiovascular events: Implications for primary prevention. Atherosclerosis. 2022 Jul; 353:11-19.
    View in: PubMed
    Score: 0.132
  30. Virani SS, Koschinsky ML, Maher L, Mehta A, Orringer CE, Santos RD, Shapiro MD, Saseen JJ. Global think tank on the clinical considerations and management of lipoprotein(a): The top questions and answers regarding what clinicians need to know. Prog Cardiovasc Dis. 2022; 73:32-40.
    View in: PubMed
    Score: 0.129
  31. German CA, Fanning J, Singleton MJ, Shapiro MD, Brubaker PH, Bertoni AG, Yeboah J. Physical Activity, Coronary Artery Calcium, and Cardiovascular Outcomes in the Multi-Ethnic Study of Atherosclerosis (MESA). Med Sci Sports Exerc. 2022 May 01; 54(5):800-806.
    View in: PubMed
    Score: 0.128
  32. Santos RD, Shapiro MD, Ballantyne CM. Glycated Hemoglobin to Detect Subclinical Atherosclerosis in People Without Diabetes. J Am Coll Cardiol. 2021 Jun 08; 77(22):2792-2795.
    View in: PubMed
    Score: 0.123
  33. Al Rifai M, Shapiro MD, Sayani S, Gulati M, Levine G, Rodriguez F, Mahtta D, Khera A, Petersen LA, Virani SS. Racial and Geographic Disparities in Internet Use in the United States Among Patients with Atherosclerotic Cardiovascular Disease. Am J Cardiol. 2020 11 01; 134:146-147.
    View in: PubMed
    Score: 0.116
  34. German CA, Shapiro MD. Small Interfering RNA Therapeutic Inclisiran: A New Approach to Targeting PCSK9. BioDrugs. 2020 Feb; 34(1):1-9.
    View in: PubMed
    Score: 0.112
  35. Shapiro MD, Maron DJ, Morris PB, Kosiborod M, Sandesara PB, Virani SS, Khera A, Ballantyne CM, Baum SJ, Sperling LS, Bhatt DL, Fazio S. Preventive Cardiology as a Subspecialty of Cardiovascular Medicine: JACC Council Perspectives. J Am Coll Cardiol. 2019 10 15; 74(15):1926-1942.
    View in: PubMed
    Score: 0.110
  36. Bamberg F, Dannemann N, Shapiro MD, Seneviratne SK, Ferencik M, Butler J, Koenig W, Nasir K, Cury RC, Tawakol A, Achenbach S, Brady TJ, Hoffmann U. Association between cardiovascular risk profiles and the presence and extent of different types of coronary atherosclerotic plaque as detected by multidetector computed tomography. Arterioscler Thromb Vasc Biol. 2008 Mar; 28(3):568-74.
    View in: PubMed
    Score: 0.049
  37. Masrouri S, Tamehri Zadeh SS, Shapiro MD, Khalili D, Hadaegh F. Impact of optimal cholesterol levels on subclinical atherosclerosis in the absence of risk factors in young adults. Atherosclerosis. 2024 Jun; 393:117520.
    View in: PubMed
    Score: 0.037
  38. Duell PB, Gidding SS, Andersen RL, Knickelbine T, Anderson L, Gianos E, Shrader P, Kindt I, O'Brien EC, McCann D, Hemphill LC, Ahmed CD, Martin SS, Larry JA, Ahmad ZS, Kullo IJ, Underberg JA, Guyton J, Thompson P, Wilemon K, Roe MT, Rader DJ, Cuchel M, Linton MF, Shapiro MD, Moriarty PM, Knowles JW. Longitudinal low density lipoprotein cholesterol goal achievement and cardiovascular outcomes among adult patients with familial hypercholesterolemia: The CASCADE FH registry. Atherosclerosis. 2019 10; 289:85-93.
    View in: PubMed
    Score: 0.027
  39. Broide E, Schopan A, Zaretsky M, Kimchi NA, Shapiro M, Scapa E. Intima-media thickness of the common carotid artery is not significantly higher in Crohn's disease patients compared to healthy population. Dig Dis Sci. 2011 Jan; 56(1):197-202.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.